...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - High Level Summary
7
Jan 07, 2016 03:54PM
2
Jan 07, 2016 03:58PM
4
Jan 07, 2016 06:25PM

Fuzzyjr

They aren't listed. They show up in my brokerage account without a listing, but a reference number and -0- market value. I have not attempted to trade, but why would I if there is no marketable value? IMHO you would be well advised to hold until the aforementioned back-door IPO occurs - who knows what the initial valuation may be - and with a trial to fund this should occur in the not too distant future.

Chicagoest

2
Jan 07, 2016 07:35PM
7
Jan 07, 2016 11:57PM
3
Jan 08, 2016 12:06AM
4
Jan 08, 2016 07:18AM
2
Jan 08, 2016 01:40PM
2
Jan 08, 2016 03:07PM
1
Jan 12, 2016 10:30AM
3
Jan 12, 2016 05:38PM
1
Jan 12, 2016 06:19PM

Jan 12, 2016 06:48PM
5
Jan 12, 2016 08:25PM
1
Jan 12, 2016 08:50PM
5
Jan 12, 2016 10:14PM
3
Jan 12, 2016 11:04PM
4
Jan 13, 2016 08:58AM
5
Jan 13, 2016 01:37PM
1
Jan 13, 2016 02:01PM
Share
New Message
Please login to post a reply